Chronic Anxiolytic Treatment: Benefit and Risk
CHRONIC TREATMENTS IN NEUROPSYCHIATRY: 173-183 (Advances in Biochemical Pharmacology Series, Vol. 40. edited by Kemali, D. and Racagni, G. N.Y.: Raven Press, 1985)
Showing items related by title, author, creator and subject.
Is It Ethical Conducting Placebo-Controlled Clinical Trials as Part of the Development of New Drugs for the Treatment of Major Depressive Disorder? (And II). Benefit/risk Ratio and Informed Consent. Conclusions Lahuerta, Juan; Gracia, Diego; Casas, Miquel; Baca, Enrique (2004-10-30)
Cheung, Bernard M. Y.; Kumana, Cyrus R. (2001-05-11)
Overholser, James C. (1995)